Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients). | ||
Founding Date | Founding Date 1989 | Founding Date 1985 | Founding Date 1904 | Founding Date 1907 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Vadodara, IN HQ Mumbai, IN Vadodara, IN | |
Employees | Employees 5,40013% increase | Employees 8,933 | Employees 7,5692% decrease | Employees 14,8582% increase |
Valuation ($) | Valuation ($) 121.6 b | Valuation ($) 4.1 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2023) | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) ₹61.1b (FY, 2024) |
Cost of goods | Cost of goods $1.3b (FY, 2023) | Cost of goods ¥4.5b (FY, 2023) | Cost of goods N/A | Cost of goods ₹19.3b (FY, 2024) |
Gross profit | Gross profit $8.6b (FY, 2023) | Gross profit ¥7.8b (FY, 2023) | Gross profit $4.5b (FY, 2020) | Gross profit ₹43b (FY, 2024) |
Net income | Net income $3.6b (FY, 2023) | Net income ¥1.9b (FY, 2023) | Net income N/A | Net income ₹6.2b (FY, 2024) |
Operating ⚠ | ||||
Trademark Applications | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A |
Trademarks | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) | Trademarks N/A |